RMC-113 induces PIP4K2C-mediated autophagy and PIKfyve-mediated viral fusion, thereby simultaneously targeting two key pathways implicated in SARS-CoV-2 and other viral infections. Here, PIKFYVE is linked to viral infectious disease.